Regulatory regions of growth-related genes can activate an exogenous gene of the α-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells

Anticancer Research

Volumn 23, Issue 4, 2003, Pages 3273-3277

  Tomizawa, Minoru ^a,b   Saisho, Hiromitsu ^b   Tagawa, Masatoshi ^a  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

fetoprotein; COX 2; Midkine; Promoter; Survivin; Telomerase

Indexed keywords

ALPHA FETOPROTEIN; CYCLOOXYGENASE 2; ENZYME; LUCIFERASE; MIDKINE; SURVIVIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; REPORTER GENE; TRANSCRIPTION INITIATION;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL DIVISION; CYCLOOXYGENASE 2; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, REPORTER; HUMANS; ISOENZYMES; LIVER NEOPLASMS; LUCIFERASES; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REGULATORY SEQUENCES, NUCLEIC ACID; TELOMERASE; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0041528195     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Miller N and Whelan J: Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 8: 803-815, 1997.
2. Nettelbeck DM, Jerome V and Muller R: Gene therapy. Designer promoters for tumour targeting. Trends in Genetics 16: 174-181, 2000.
3. Tamaoki T: Human alpha-fetoprotein transcriptional regulatory sequences. Application to gene therapy. Adv Exp Med Biol 465: 47-56, 2000.
4. Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y, Tamaoki T, Ishii N and Nakata K: Retrovirus-mediated gene therapy for hepatocellular carcinoma: Selective and enhanced suicide gene expression regulated by human α-fetoprotein enhancer directly linked to its promoter. Cancer Gene Ther 5: 301-306, 1998.
5. Hallenbeck PL, Chang YN, Hay C, Golightly D, Stewart D, Lin J, Phipps S and Chiang YL: A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma. Hum Gene Ther 10: 1721-1733, 1999.
6. Di Bisceglie AM, Dusheiko GM, Paterson AC, Alexander J, Shouval D, Lee CS, Beasley RP and Kew MC: Detection of alpha-foetoprotein messenger RNA in human hepatocellular carcinoma and hepatoblastoma tissue. Br J Cancer 54: 779-785, 1986.
7. Varagona G, Brown D, Haase A and Dusheiko G: Increased steady-state levels of alpha-fetoprotein mRNA in hepatocellular carcinoma: an analysis by in situ hybridization. Liver 12: 62-68, 1992.
8. Nakabayashi H, Hashimoto T, Miyao Y, Tjong KK, Chan J and Tamaoki T: A position-dependent silencer plays a major role in repressing α-fetoprotein expression in human hepatoma. Mol Cell Biol 11: 5885-5893, 1991.
9. Shirota Y, Kaneko S, Honda M, Kawai HF and Kobayashi K: Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 33: 832-840, 2001.
10. Aridome K, Tsutsui J, Takao S, Kadomatsu K, Ozawa M, Aikou T and Muramatsu T: Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res 86: 655-661, 1995.
11. Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG and Ryu WS: Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin Cancer Res 7: 1410-1418, 2001.
12. Toshikuni N, Nouso K, Higashi T, Nakatsukasa H, Onishi T, Kaneyoshi T, Kobayashi Y, Kariyama K, Yamamoto K and Tsuji T: Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma. Br J Cancer 82: 833-837, 2000.
13. Fengzhi LI and Altieri DC: Transcriptional analysis of human survivin gene expression. Biochem J 344: 305-311, 1999.
14. Agui T, McConkey DJ and Tanigawa N: Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas. Anticancer Res 22: 1769-1776, 2002.
15. Kadomatsu K, Tomomura M and Muramatsu T: cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 151: 1312-1318, 1988.
16. Morinaga T, Sakai M, Wegmann TG and Tamaoki T: Primary structures of human α-fetoprotein and its mRNA. Proc Natl Acad Sci USA 80: 4604-4608, 1983.
17. Uehara K, Matsubara S, Kadomatsu K, Tsutsui J and Muramatsu T: Genomic structure of human midkine (MK), a retinoic acid-responsive growth/differentiation factor. J Biochem 111: 563-567, 1992.
18. Niwa Y, Matsumura M, Shiratori Y, Imamura M, Kato N, Shiina S, Okudaira T, Ikeda Y, Inoue T and Omata M: Quantitation of α-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma. Hepatology 23: 1384-1392, 1996.
19. Miyauchi M, Shimada H, Kadomatsu K, Muramatsu T, Matsubara S, Ikematsu S, Takenaga K, Asano T, Ochiai T, Sakiyama S and Tagawa M: Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy. Jpn J Cancer Res 90: 469-475, 1999.
20. Miyauchi M, Yoshida Y, Tada Y, Narita M, Maeda T, Bahar R, Kadomatsu K, Muramatsu T, Matsubara S, Nakagawara A, Sakiyama S and Tagawa M: Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells. Int J Cancer 91: 723-727, 2001.
21. Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921, 1997.
22. Li F and Altieri DC: Transcriptional analysis of human surviving gene expression. Biochem J 344: 305-311, 1999.
23. Bao R, Connolly DC, Murphy M, Green J, Weinstein JK, Pisarcik DA and Hamilton TC: Activation of cancer-specific gene expression by the survivin promoter. J Natl Cancer Inst 94: 522-528, 2002.
24. Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK and Keith WN: Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 14: 1013-1021, 1997.
25. Abdul-Ghani R, Ohana P, Matouk I, Ayesh S, Ayech B, Laster M, Bibi O, Giladi H, Molnar-Kimber K, Sughayer MA, Groot ND and Hochberg A: Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells. Mol Ther 2: 539-544, 2000.
26. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB and Lipsky PE: Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073, 1998.
27. Eszterhas SK, Bouhassira EE, Martin DIK and Fiering S: Transcriptional interference by independently regulated genes occurs in any relative arrangement of the genes and is influenced by chromosomal integration position. Mol Cell Bio 22: 469-479, 2002
28. Hangstrom JN, Couto LB, Scallan C, Burton M and McCleland ML: Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter. Blood 95: 2536-2542, 2000.
29. Yoshida Y, Tomizawa M, Bahar R, Miyauchi M, Yamaguchi T, Saisho H, Kadomatsu K, Muramatsu T, Matsubara S, Sakiyama S and Tagawa M: A promoter region of midkine gene can activate transcription of an exogenous suicide gene in human pancreatic cancer. Anticancer Res 22: 117-120, 2002.